Members |
acceptabilityId |
422 |
Acceptable (foundation metadata concept) |
423 |
Acceptable (foundation metadata concept) |
424 |
Acceptable (foundation metadata concept) |
425 |
Preferred (foundation metadata concept) |
425 |
Acceptable (foundation metadata concept) |
425 (qualifier value) |
Preferred (foundation metadata concept) |
428 |
Preferred (foundation metadata concept) |
428 (qualifier value) |
Preferred (foundation metadata concept) |
43 |
Acceptable (foundation metadata concept) |
43 |
Preferred (foundation metadata concept) |
43 (qualifier value) |
Preferred (foundation metadata concept) |
43-K |
Acceptable (foundation metadata concept) |
4320 |
Preferred (foundation metadata concept) |
4320 (qualifier value) |
Preferred (foundation metadata concept) |
44 |
Preferred (foundation metadata concept) |
44 |
Acceptable (foundation metadata concept) |
44 (qualifier value) |
Preferred (foundation metadata concept) |
44-Ti |
Acceptable (foundation metadata concept) |
440 |
Preferred (foundation metadata concept) |
440 (qualifier value) |
Preferred (foundation metadata concept) |
4400 |
Preferred (foundation metadata concept) |
4400 (qualifier value) |
Preferred (foundation metadata concept) |
44000 |
Preferred (foundation metadata concept) |
44000 (qualifier value) |
Preferred (foundation metadata concept) |
45 |
Acceptable (foundation metadata concept) |
45 |
Preferred (foundation metadata concept) |
45 (qualifier value) |
Preferred (foundation metadata concept) |
45 degree projection |
Preferred (foundation metadata concept) |
45 degree projection (qualifier value) |
Preferred (foundation metadata concept) |
45 minute serum GH level |
Preferred (foundation metadata concept) |
45 minute serum growth hormone measurement |
Acceptable (foundation metadata concept) |
45 minute serum growth hormone measurement (procedure) |
Preferred (foundation metadata concept) |
45, X syndrome |
Acceptable (foundation metadata concept) |
45, X/46, XY mosaicism |
Acceptable (foundation metadata concept) |
45-Ca |
Acceptable (foundation metadata concept) |
45-Ti |
Acceptable (foundation metadata concept) |
450 |
Preferred (foundation metadata concept) |
450 (qualifier value) |
Preferred (foundation metadata concept) |
4500 |
Preferred (foundation metadata concept) |
4500 (qualifier value) |
Preferred (foundation metadata concept) |
45000 |
Preferred (foundation metadata concept) |
45000 (qualifier value) |
Preferred (foundation metadata concept) |
451 |
Preferred (foundation metadata concept) |
451 (qualifier value) |
Preferred (foundation metadata concept) |
454 |
Preferred (foundation metadata concept) |
454 (qualifier value) |
Preferred (foundation metadata concept) |
454000 |
Preferred (foundation metadata concept) |
454000 (qualifier value) |
Preferred (foundation metadata concept) |
458 |
Preferred (foundation metadata concept) |
458 (qualifier value) |
Preferred (foundation metadata concept) |
45XO - Turner's syndrome |
Acceptable (foundation metadata concept) |
46 |
Acceptable (foundation metadata concept) |
46 XY disorder of sex development due to maternal ingestion of estrogen |
Preferred (foundation metadata concept) |
46 XY disorder of sex development due to maternal ingestion of estrogen (disorder) |
Preferred (foundation metadata concept) |
46, XX true hermaphrodite |
Preferred (foundation metadata concept) |
46, XX true hermaphrodite (disorder) |
Preferred (foundation metadata concept) |
46,XX androgen-induced disorder of sex development due to maternal adrenal hyperplasia |
Preferred (foundation metadata concept) |
46,XX androgen-induced disorder of sex development due to maternal adrenal hyperplasia (disorder) |
Preferred (foundation metadata concept) |
46,XX androgen-induced disorder of sex development of iatrogenic maternal origin |
Preferred (foundation metadata concept) |
46,XX androgen-induced disorder of sex development of iatrogenic maternal origin (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development |
Preferred (foundation metadata concept) |
46,XX disorder of sex development (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development caused by synthetic oral diethylstilbestrol |
Preferred (foundation metadata concept) |
46,XX disorder of sex development caused by synthetic oral diethylstilbestrol (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development caused by synthetic oral progestogen |
Acceptable (foundation metadata concept) |
46,XX disorder of sex development caused by synthetic oral progestogen (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development caused by testosterone and/or testosterone derivative |
Preferred (foundation metadata concept) |
46,XX disorder of sex development caused by testosterone and/or testosterone derivative (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal Krukenberg neoplasm |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal Krukenberg neoplasm (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal adrenal neoplasm |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal adrenal neoplasm (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal androluteoma |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal androluteoma (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal arrhenoblastoma |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to maternal arrhenoblastoma (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to synthetic oral diethylstilbestrol |
Acceptable (foundation metadata concept) |
46,XX disorder of sex development due to synthetic oral progestogen |
Preferred (foundation metadata concept) |
46,XX disorder of sex development due to testosterone and/or testosterone derivative |
Acceptable (foundation metadata concept) |
46,XX disorder of sex development with anorectal anomalies syndrome |
Preferred (foundation metadata concept) |
46,XX disorder of sex development with anorectal anomalies syndrome (disorder) |
Preferred (foundation metadata concept) |
46,XX disorder of sex development with skeletal anomalies syndrome |
Preferred (foundation metadata concept) |
46,XX disorder of sex development with skeletal anomalies syndrome (disorder) |
Preferred (foundation metadata concept) |
46,XX gonadal dysgenesis |
Acceptable (foundation metadata concept) |
46,XX ovotesticular disorder of sex development |
Preferred (foundation metadata concept) |
46,XX ovotesticular disorder of sex development (disorder) |
Preferred (foundation metadata concept) |
46,XX testicular disorder of sex development |
Preferred (foundation metadata concept) |
46,XX testicular disorder of sex development (disorder) |
Preferred (foundation metadata concept) |
46,XY disorder of sex development |
Preferred (foundation metadata concept) |
46,XY disorder of sex development (disorder) |
Preferred (foundation metadata concept) |
46,XY disorder of sex development due to environmental chemical exposure |
Preferred (foundation metadata concept) |
46,XY disorder of sex development due to environmental chemical exposure (disorder) |
Preferred (foundation metadata concept) |
46,XY disorder of sex development due to isolated 17,20-lyase deficiency |
Preferred (foundation metadata concept) |
46,XY disorder of sex development due to isolated 17,20-lyase deficiency (disorder) |
Preferred (foundation metadata concept) |
46,XY disorder of sex development due to maternal ingestion of progestogen |
Preferred (foundation metadata concept) |
46,XY disorder of sex development due to maternal ingestion of progestogen (disorder) |
Preferred (foundation metadata concept) |
46,XY disorder of sex development, adrenal insufficiency due to CYP11A1 deficiency |
Preferred (foundation metadata concept) |
46,XY disorder of sex development, adrenal insufficiency due to cytochrome P450 family 11 subfamily A member 1 deficiency |
Acceptable (foundation metadata concept) |
46,XY disorder of sex development, adrenal insufficiency due to cytochrome P450 family 11 subfamily A member 1 deficiency (disorder) |
Preferred (foundation metadata concept) |
46,XY gonadal dysgenesis, motor and sensory neuropathy syndrome |
Preferred (foundation metadata concept) |
46,XY gonadal dysgenesis, motor and sensory neuropathy syndrome (disorder) |
Preferred (foundation metadata concept) |